Navigation Links
RSB Spine, LLC, Announces European Patent Allowance
Date:11/15/2011

CLEVELAND, Nov. 15, 2011 /PRNewswire/ -- RSB Spine, LLC, today announced allowance of  European Patent 1847240 covering specific design iterations of its line of InterPlate® cervical and lumbar intervertebral fusion devices.

"Fusion remains one of the most common spinal procedures performed by neurosurgeons and orthopedic surgeons, despite the introduction of numerous disc replacement implants," commented James M. Moran, D. Eng., the company's chief technical officer. "This intellectual property reinforces RSB's freedom to respond to evolving surgeon preferences and supports our plans for European sales. Ongoing legal disputes also highlight the need for medical device companies to have the protection of a strong patent portfolio."

In July, the company received a United States Patent involving design of interbody devices that prevent stress shielding, complementing a previous European approval for the same concepts.

RSB Spine is a privately held medical device company. News releases and other information on the company are available on the Internet at: www.rsbspine.com and www.paradigmbiodevices.com.


'/>"/>
SOURCE RSB Spine, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. RSB Spine, LLC, Announces Distribution Agreement with Paradigm BioDevices, Inc.
2. RSB Spine, LLC, Announces FDA Clearance for the InterPlate(R) C-Ti as an Anterior Cervical Plate
3. RSB Spine, LLC, Announces Additional FDA Clearance for the InterPlate® L-Ti
4. Amedica® Corporation Acquires US Spine, Further Securing Its Leadership Position in the Spinal Device Marketplace
5. RSB Spine, LLC, Announces Record Third-Quarter 2010 Revenue and Offering Completion
6. RSB Spine, LLC, Announces Record 2010 Revenue Growth
7. RSB Spine, LLC, Announces Record First-Quarter 2011 Revenue
8. RSB Spine, LLC, Announces Record Second-Quarter 2011 Revenue
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , May 25, 2016  Granger Diagnostics today ... test for wounds and infections. This test ensures ... and select viruses. The test requires only a ... David G. Bostwick , MD, ... to facilitate wound healing: "We are excited to ...
(Date:5/24/2016)... May 24, 2016 Niederländische ... gebracht, die es Ärzten erlaubt, ihre Expertise weltweit ... MDLinking kombiniert Live Streaming mit einer Instant-Messaging-Funktion und ... kommunizieren. Mediziner in Europa, Afrika, Asien und den ... für die Plattform registriert. Information und ...
(Date:5/24/2016)... 24, 2016 ARANZ Medical  Ltd ... healthcare sector, has been named the Coretex Hi-Tech Emerging Company ... Dr Bruce Davey , CEO of ARANZ ...  It,s really good to be recognised for the work we ... are used in 35 countries around the world from Sub-Saharan ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac arrhythmia is ... impact on long-term patient survival, reports a team of UPMC researchers in the ... in the Journal of Thoracic and Cardiovascular Surgery, provide critical information that will ...
(Date:5/26/2016)... ... May 26, 2016 , ... MadgeTech will be showcasing its ... manufactured in Warner, New Hampshire at the MadgeTech headquarters. With products sold in more ... trusted by government agencies, including NASA. , In 2012, NASA strategically set up ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... Retinal Degeneration” for the Foundation Fighting Blindness, Long Island Chapter on June 4, ... the public. , Dr. Maisel, founder of Retina Group of New York ...
(Date:5/26/2016)... ... ... In an effort to provide hair restoration information to the widest possible audience, Dr. Parsa ... not use the app. Dr. Mohebi, the founder of Parsa Mohebi Hair Restoration, is making ... , Dr. Mohebi says, “The positive response to the Snapchat videos we started last month ...
(Date:5/26/2016)... ... May 26, 2016 , ... Leadership of Life Science Logistics ... organization has earned its ISO 13485 certification, indicating the company’s quality control system ... and policies associated with ISO quality standard 13485. , BSI Group America, ...
Breaking Medicine News(10 mins):